The aim of this article was to heighten awareness of the role of early identification and diagnosis of eating disorders, especially anorexia nervosa and bulimia nervosa, in the primary care setting.
Read more
Purpose of this guideline The purpose of this guideline is to provide evidence-based guidance about the identification, assessment, and management of suicide and NSSI in children and adolescents (0-19 years) to ensure optimal and consistent care.
Read more
This Information Sheet was developed by Eating Disorders Neurodiversity Australia.
Read more
Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more
